Free Trial

Nomura Asset Management Co. Ltd. Buys 19,093 Shares of The Allstate Co. (NYSE:ALL)

Allstate logo with Finance background

Nomura Asset Management Co. Ltd. boosted its position in The Allstate Co. (NYSE:ALL - Free Report) by 25.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 94,174 shares of the insurance provider's stock after acquiring an additional 19,093 shares during the quarter. Nomura Asset Management Co. Ltd.'s holdings in Allstate were worth $17,860,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the business. FSA Wealth Management LLC acquired a new stake in Allstate during the 3rd quarter valued at approximately $26,000. Northwest Investment Counselors LLC bought a new position in Allstate during the third quarter worth $28,000. Catalyst Capital Advisors LLC bought a new stake in Allstate during the third quarter valued at $29,000. Family Firm Inc. acquired a new stake in Allstate during the 2nd quarter worth about $38,000. Finally, MCF Advisors LLC raised its position in shares of Allstate by 33.9% in the 2nd quarter. MCF Advisors LLC now owns 332 shares of the insurance provider's stock worth $53,000 after acquiring an additional 84 shares in the last quarter. Institutional investors and hedge funds own 76.47% of the company's stock.

Allstate Stock Performance

ALL traded down $1.84 during trading on Wednesday, hitting $193.22. 1,541,433 shares of the company traded hands, compared to its average volume of 1,551,107. The Allstate Co. has a one year low of $134.17 and a one year high of $209.88. The stock's fifty day moving average is $194.69 and its 200 day moving average is $180.92. The firm has a market cap of $51.16 billion, a P/E ratio of 12.52, a price-to-earnings-growth ratio of 1.79 and a beta of 0.50. The company has a quick ratio of 0.40, a current ratio of 0.40 and a debt-to-equity ratio of 0.43.

Allstate (NYSE:ALL - Get Free Report) last announced its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share for the quarter, beating the consensus estimate of $2.20 by $1.71. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The business had revenue of $16.63 billion during the quarter, compared to analyst estimates of $14.57 billion. During the same period in the prior year, the company earned $0.81 earnings per share. Allstate's revenue was up 14.7% compared to the same quarter last year. As a group, equities analysts predict that The Allstate Co. will post 16.26 EPS for the current fiscal year.

Allstate Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 2nd. Investors of record on Friday, November 29th will be paid a $0.92 dividend. This represents a $3.68 dividend on an annualized basis and a yield of 1.90%. The ex-dividend date of this dividend is Friday, November 29th. Allstate's dividend payout ratio is currently 23.83%.

Insiders Place Their Bets

In related news, insider John E. Dugenske sold 36,367 shares of the business's stock in a transaction on Friday, September 20th. The stock was sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the sale, the insider now directly owns 27,364 shares in the company, valued at approximately $5,236,922.32. The trade was a 57.06 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 1.80% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the stock. Evercore ISI raised their price objective on shares of Allstate from $191.00 to $195.00 and gave the stock an "in-line" rating in a research report on Wednesday, October 9th. StockNews.com downgraded Allstate from a "strong-buy" rating to a "buy" rating in a research note on Wednesday, August 21st. Keefe, Bruyette & Woods upped their price target on Allstate from $222.00 to $225.00 and gave the stock an "outperform" rating in a research note on Wednesday, November 6th. Roth Mkm reissued a "buy" rating and issued a $200.00 price objective on shares of Allstate in a research note on Wednesday, August 14th. Finally, UBS Group upped their target price on Allstate from $216.00 to $225.00 and gave the stock a "buy" rating in a research report on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $217.19.

Check Out Our Latest Stock Report on Allstate

Allstate Profile

(Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Featured Articles

Institutional Ownership by Quarter for Allstate (NYSE:ALL)

Should you invest $1,000 in Allstate right now?

Before you consider Allstate, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.

While Allstate currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines